RespireRx Pharmaceuticals Inc (fka RSPI)

[DewDiligence]

[OT] IDIX / HBV addressable market:

>…with an approved product in a huge indication.<

I would not characterize HBV as a huge indication in the developed part of the world—I think it’s more apt to say HBV is a rapidly growing market that is still in its infancy and is poorly understood by many investors.

Here are some references on the topic:

#msg-18909904 Chart of market growth/market share
#msg-11099728 Prevalence in Asian-American population
#msg-11058133 Ditto
#msg-14285923 Misc. background info

Dew